Clinical Trial Update: Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intraosseous vancomycin in primary total hip arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Prosthetic Joint Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prosthetic Joint Infection, Vancomycin | Phase 4 | Status: COMPLETED | Results posted: 2025-03-13